Literature DB >> 16675907

Transanal endoscopic microsurgery: where are we now?

Sushil Maslekar1, Daniel L Beral, Tim J White, Steve H Pillinger, John R T Monson.   

Abstract

AIMS: This review of literature aimed to assess the role and establish the current status of transanal endoscopic microsurgery (TEM) in the management of benign and malignant rectal lesions.
METHODS: A review of the literature was undertaken through the Medline database and by cross-referencing previous publications, thus identifying 54 relevant publications on TEM in the management of rectal lesions. Aggregated results of various parameters were calculated but statistical comparisons deemed unsuitable due to heterogeneity of data.
RESULTS: The TEM procedure is associated with good functional results, morbidity of 4% and zero procedure-related mortality. The local recurrence rates after TEM excision is 4.5% (range 0-14) for benign rectal lesions, 6% (0-13) for T(1) cancers, 14% (range 0-50) for T(2) cancers and 20% (range 14-67%) for T(3) cancers. Local recurrences after TEM can be surgically salvaged with good disease free survival rates.
CONCLUSIONS: The TEM procedure clearly offers the benefits of good exposure of the operative field allowing extremely precise dissection and access to high rectal lesions unresectable by other methods. For pTis and low risk pT(1) lesions, the oncological results are comparable to the more traditional formal resection. The routine use of TEM for high-risk pT(1) and higher stage lesions is not an oncologically sound choice at the present moment.

Entities:  

Mesh:

Year:  2006        PMID: 16675907     DOI: 10.1159/000091957

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  9 in total

1.  Colorectal Cancer OncoGuia.

Authors:  Paula Manchon Walsh; Josep M Borràs; Tàrsila Ferro; Josep Alfons Espinàs
Journal:  Clin Transl Oncol       Date:  2010-03       Impact factor: 3.405

2.  Transanal endoscopic operation for rectal lesions using two-dimensional visualization and standard endoscopic instruments: a prospective cohort study and comparison with the literature.

Authors:  D H Nieuwenhuis; W A Draaisma; G H M Verberne; A J van Overbeeke; E C J Consten
Journal:  Surg Endosc       Date:  2008-04-29       Impact factor: 4.584

3.  Total laparoscopic sigmoid and rectal surgery in combination with transanal endoscopic microsurgery: a preliminary evaluation in China.

Authors:  Yi Han; Yong-Gang He; Hao-Bo Zhang; Ke-Zhi Lv; Ya-Jie Zhang; Mou-Bin Lin; Lu Yin
Journal:  Surg Endosc       Date:  2012-07-18       Impact factor: 4.584

4.  TEMS: results of a specialist centre.

Authors:  S M Flexer; A C Durham-Hall; M A Steward; J M Robinson
Journal:  Surg Endosc       Date:  2014-01-11       Impact factor: 4.584

Review 5.  Surgical Options in the Treatment of Lower Gastrointestinal Tract Cancers.

Authors:  Andrea S Porpiglia; Elin R Sigurdson
Journal:  Curr Treat Options Oncol       Date:  2015-09

6.  Postoperative complications in the treatment of rectal neoplasia by transanal endoscopic microsurgery: a prospective study of risk factors and time course.

Authors:  Carlos Frederico S Marques; Caio Sergio R Nahas; Ulysses Ribeiro; Leonardo A Bustamante; Rodrigo Ambar Pinto; Eduardo Kenzo Mory; Ivan Cecconello; Sergio Carlos Nahas
Journal:  Int J Colorectal Dis       Date:  2016-02-09       Impact factor: 2.571

7.  'How I do it': TEM for tumors of the rectum.

Authors:  Rowan J Collinson; Neil J McC Mortensen
Journal:  J Gastrointest Surg       Date:  2008-05-06       Impact factor: 3.452

8.  Long-term outcomes of transanal endoscopic microsurgery for clinical complete response after neoadjuvant treatment in T2-3 rectal cancer.

Authors:  Javier Ernesto Barreras González; Haslen Cáceres Lavernia; Jorge Gerardo Pereira Fraga; Solvey Quesada Lemus
Journal:  Surg Endosc       Date:  2021-07-06       Impact factor: 4.584

9.  TEM in the treatment of recurrent rectal cancer in elderly.

Authors:  Stefano Perrotta; Gennaro Quarto; Vincenzo Desiato; Gianluca Benassai; Bruno Amato; Giacomo Benassai
Journal:  BMC Surg       Date:  2013-10-08       Impact factor: 2.102

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.